KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Freeport-Mcmoran (FCX) Research & Development (2016 - 2025)

Freeport-Mcmoran (FCX) has disclosed Research & Development for 17 consecutive years, with $52.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 26.83% to $52.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $192.0 million through Dec 2025, up 23.08% year-over-year, with the annual reading at $192.0 million for FY2025, 23.08% up from the prior year.
  • Research & Development for Q4 2025 was $52.0 million at Freeport-Mcmoran, down from $55.0 million in the prior quarter.
  • The five-year high for Research & Development was $55.0 million in Q3 2025, with the low at $7.0 million in Q1 2021.
  • Average Research & Development over 5 years is $32.8 million, with a median of $35.5 million recorded in 2023.
  • The sharpest move saw Research & Development plummeted 56.25% in 2021, then skyrocketed 242.86% in 2022.
  • Over 5 years, Research & Development stood at $19.0 million in 2021, then surged by 47.37% to $28.0 million in 2022, then grew by 21.43% to $34.0 million in 2023, then rose by 20.59% to $41.0 million in 2024, then increased by 26.83% to $52.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $52.0 million, $55.0 million, and $46.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.